Smoking Cessation Interventions for Lung Cancer Patients
2013; Future Medicine; Volume: 2; Issue: 1 Linguagem: Inglês
10.2217/lmt.12.55
ISSN1758-1974
AutoresKristin Carson‐Chahhoud, Zafar A Usmani, Thomas A. Robertson, Satya Mysore, Malcolm P Brinn,
Tópico(s)Cancer Risks and Factors
ResumoSUMMARY Worldwide, lung cancer contributes to over 1.4 million deaths per year. Smoking cessation is strongly recommended in clinical practice guidelines for lung cancer management, yet evidence suggests a translational gap between evidence and practice. There are significant health benefits following smoking cessation even after a short period of time. Long-term implications for lung cancer patients include improvements in quality of life, reductions in postoperative complications and reductions in 12-month mortality. Evidence suggests that combining pharmacotherapy, in particular varenicline tartrate (varenicline), with cognitive and behavioral interventions offers the best opportunity for successful long-term abstinence. This review summarizes the latest evidence for smoking cessation interventions in lung cancer patients, identifies gaps in current clinical practice and highlights priority areas for future research.
Referência(s)